-- FACTBOX: Largest biotechnology deals in 2007
-- 
-- Mon Oct 15, 2007 4:16pm EDT
-- http://www.reuters.com/article/2007/10/15/us-biotech-idUSN1537340720071015

 

 (Reuters) - Biotechnology company Biogen Idec Inc. ( BIIB.O ) on 
Friday had put itself up for sale after receiving expressions of interest from parties including billionaire financier Carl Icahn. Investors speculated on Monday that biotech companies such as Genzyme Corp. GENZ.O could be targeted next. 

 Below is a list of the largest global biotechnology deals this year, 
according to research firm Dealogic. 
BUYER                  TARGET COMPANY                   DEAL VALUE 
AstraZeneca Plc        MedImmune Inc.                   $14.9 billion 
Schering-Plough Corp.  Organon BioSciences NV           $14.4 billion 
Mylan Laboratories     Merck KGaA (generic drug unit)   $6.6 billion 
Novator                Actavis Group (61.5 pct stake)   $4.5 billion 
Tanabe Seiyaku Co.     Mitsubishi Pharma Corp.          $3.8 billion 
SOURCE: Dealogic